Bank of America’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.47M Sell
25,646
-4,665
-15% -$467K ﹤0.01% 3969
2025
Q4
$2.95M Buy
30,311
+9,888
+48% +$848K ﹤0.01% 3771
2025
Q3
$1.45M Sell
20,423
-1,717
-8% -$114K ﹤0.01% 5082
2025
Q2
$1.32M Sell
22,140
-249
-1% -$13.6K ﹤0.01% 5099
2025
Q1
$1.17M Sell
22,389
-3,582
-14% -$201K ﹤0.01% 5111
2024
Q4
$1.43M Buy
25,971
+1,949
+8% +$103K ﹤0.01% 4738
2024
Q3
$1.21M Buy
24,022
+8,819
+58% +$407K ﹤0.01% 4930
2024
Q2
$668K Buy
15,203
+1,716
+13% +$73K ﹤0.01% 5159
2024
Q1
$593K Buy
13,487
+239
+2% +$10.6K ﹤0.01% 5247
2023
Q4
$629K Buy
13,248
+4,759
+56% +$200K ﹤0.01% 5325
2023
Q3
$377K Buy
8,489
+3,465
+69% +$161K ﹤0.01% 5516
2023
Q2
$240K Sell
5,024
-3,283
-40% -$148K ﹤0.01% 5723
2023
Q1
$327K Buy
8,307
+3,306
+66% +$120K ﹤0.01% 5649
2022
Q4
$141K Buy
5,001
+2,942
+143% +$84.2K ﹤0.01% 6102
2022
Q3
$62K Sell
2,059
-4,592
-69% -$160K ﹤0.01% 6572
2022
Q2
$226K Buy
6,651
+3,046
+84% +$109K ﹤0.01% 6002
2022
Q1
$162K Sell
3,605
-6,519
-64% -$301K ﹤0.01% 6591
2021
Q4
$467K Sell
10,124
-2,502
-20% -$101K ﹤0.01% 5932
2021
Q3
$423K Buy
12,626
+1,866
+17% +$63.5K ﹤0.01% 5783
2021
Q2
$317K Sell
10,760
-3,408
-24% -$93.9K ﹤0.01% 5765
2021
Q1
$365K Sell
14,168
-159
-1% -$3.8K ﹤0.01% 5620
2020
Q4
$326K Buy
14,327
+1,091
+8% +$25.2K ﹤0.01% 5284
2020
Q3
$283K Sell
13,236
-437
-3% -$9.81K ﹤0.01% 5085
2020
Q2
$317K Buy
13,673
+5,301
+63% +$114K ﹤0.01% 4959
2020
Q1
$179K Sell
8,372
-280
-3% -$6.67K ﹤0.01% 5145
2019
Q4
$202K Sell
8,652
-15,618
-64% -$365K ﹤0.01% 5637
2019
Q3
$510K Buy
24,270
+7,607
+46% +$155K ﹤0.01% 5071
2019
Q2
$341K Sell
16,663
-815
-5% -$19.2K ﹤0.01% 5317
2019
Q1
$490K Sell
17,478
-2,054
-11% -$53.8K ﹤0.01% 5030
2018
Q4
$477K Buy
19,532
+3,882
+25% +$104K ﹤0.01% 4964
2018
Q3
$582K Buy
15,650
+857
+6% +$23.1K ﹤0.01% 4847
2018
Q2
$307K Buy
14,793
+14,406
+3,722% +$255K ﹤0.01% 5174
2018
Q1
$6K Buy
+387
New +$5.51K ﹤0.01% 6730
2017
Q3
Sell
-1,637
Closed -$14K 7152
2017
Q2
$14K Sell
1,637
-47
-3% -$401 ﹤0.01% 6332
2017
Q1
$15K Buy
1,684
+1,129
+203% +$10.5K ﹤0.01% 6414
2016
Q4
$6K Sell
555
-473
-46% -$5.09K ﹤0.01% 6664
2016
Q3
$17K Sell
1,028
-2,931
-74% -$54.3K ﹤0.01% 6193
2016
Q2
$86K Buy
+3,959
New +$71.2K ﹤0.01% 5596
2016
Q1
Sell
-5,414
Closed -$152K 7153
2015
Q4
$152K Buy
5,414
+841
+18% +$23.8K ﹤0.01% 5536
2015
Q3
$111K Buy
4,573
+1,494
+49% +$35.7K ﹤0.01% 5622
2015
Q2
$72K Buy
3,079
+79
+3% +$1.44K ﹤0.01% 5765
2015
Q1
$46K Hold
3,000
﹤0.01% 5698
2014
Q4
$39K Buy
+3,000
New +$25.9K ﹤0.01% 6475

Other funds holding IRMD

Bank of America's IRMD Position: Q1 2026 in Review

Bank of America reduced its iRadimed (IRMD) stake by 15% in Q1 2026, selling an estimated $467K and leaving 25,646 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3969.

Bank of America first reported a position in IRMD in Q4 2014 and has held it in 43 quarters since. The position peaked at $2.95M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Bank of America held 25,646 shares of iRadimed worth $2.47M as of Q1 2026.
  • Bank of America sold 4,665 iRadimed shares in Q1 2026, an estimated $467K.
  • iRadimed made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3969 holding.
  • Bank of America first reported a position in iRadimed in Q4 2014 and has held it in 43 quarters since.
  • Bank of America's iRadimed position peaked at $2.95M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.